We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AROC icon
1376
Archrock
AROC
$5.88B
$31K ﹤0.01%
2,404
+1,935
+413% +$20.8K
CHT icon
1377
Chunghwa Telecom
CHT
$32.8B
$31K ﹤0.01%
+898
New +$32.6K
CPK icon
1378
Chesapeake Utilities
CPK
$3.2B
$31K ﹤0.01%
502
+384
+325% +$24.6K
EPOL icon
1379
iShares MSCI Poland ETF
EPOL
$753M
$31K ﹤0.01%
+1,726
New +$30.9K
GIL icon
1380
Gildan
GIL
$10.8B
$31K ﹤0.01%
1,115
-589
-35% -$17.4K
MAN icon
1381
ManpowerGroup
MAN
$2.56B
$31K ﹤0.01%
435
-2,549
-85% -$176K
BCIC
1382
BCP Investment Corp
BCIC
$91.2M
$31K ﹤0.01%
666
+569
+587% +$24.1K
RH icon
1383
RH
RH
$3.54B
$31K ﹤0.01%
910
-11,675
-93% -$372K
SKYW icon
1384
Skywest
SKYW
$4.42B
$31K ﹤0.01%
1,189
+992
+504% +$27.5K
TDC icon
1385
Teradata
TDC
$2.55B
$31K ﹤0.01%
997
-2,689
-73% -$80.1K
THC icon
1386
Tenet Healthcare
THC
$20.7B
$31K ﹤0.01%
1,356
-2,291
-63% -$59.6K
USNA icon
1387
Usana Health Sciences
USNA
$271M
$31K ﹤0.01%
454
-68
-13% -$4.49K
NPKI
1388
NPK International
NPKI
$1.16B
$31K ﹤0.01%
4,161
-4,897
-54% -$32.4K
STZ.B
1389
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
$31K ﹤0.01%
185
-20
-10% -$3.32K
CTT
1390
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$31K ﹤0.01%
2,637
+1,633
+163% +$19.3K
XLRN
1391
DELISTED
Acceleron Pharma
XLRN
$31K ﹤0.01%
+864
New +$28.6K
CBL
1392
DELISTED
CBL& Associates Properties, Inc.
CBL
$31K ﹤0.01%
2,515
+287
+13% +$3.5K
TVIX
1393
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
$31K ﹤0.01%
+2
New +$54.4K
CTIC
1394
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$31K ﹤0.01%
8,288
-651
-7% -$2.37K
REGI
1395
DELISTED
Renewable Energy Group, Inc.
REGI
$31K ﹤0.01%
+3,687
New +$32.6K
FTR
1396
DELISTED
Frontier Communications Corp.
FTR
$31K ﹤0.01%
510
+506
+12,650% +$36K
AMED
1397
DELISTED
Amedisys
AMED
$30K ﹤0.01%
638
+527
+475% +$26.3K
BBDC icon
1398
Barings BDC
BBDC
$956M
$30K ﹤0.01%
1,504
-4,478
-75% -$88.4K
CDW icon
1399
CDW
CDW
$18.2B
$30K ﹤0.01%
+670
New +$29.4K
CMPR icon
1400
Cimpress
CMPR
$2.28B
$30K ﹤0.01%
301
-1,020
-77% -$99.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.